Siemens Healthineers AG

XETRA SHL.DE

Siemens Healthineers AG Price to Book Ratio (P/B) on January 14, 2025: 2.98

Siemens Healthineers AG Price to Book Ratio (P/B) is 2.98 on January 14, 2025, a -11.66% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • Siemens Healthineers AG 52-week high Price to Book Ratio (P/B) is 3.69 on March 08, 2024, which is 23.84% above the current Price to Book Ratio (P/B).
  • Siemens Healthineers AG 52-week low Price to Book Ratio (P/B) is 2.84 on November 21, 2024, which is -4.58% below the current Price to Book Ratio (P/B).
  • Siemens Healthineers AG average Price to Book Ratio (P/B) for the last 52 weeks is 3.28.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
Loading...
XETRA: SHL.DE

Siemens Healthineers AG

CEO Dr. Bernhard Montag Ph.D.
IPO Date April 12, 2018
Location Germany
Headquarters Henkestrasse 127
Employees 72,300
Sector Health Care
Industries
Description

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Similar companies

SY1.DE

Symrise AG

USD 99.35

-2.63%

ENR.DE

Siemens Energy AG

USD 52.40

3.90%

FRE.DE

Fresenius SE & Co. KGaA

USD 35.88

1.39%

SIE.DE

Siemens Aktiengesellschaft

USD 199.90

1.01%

StockViz Staff

January 15, 2025

Any question? Send us an email